• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 35 of 100
Who should get get the COVID-19 vaccine?
CommentaryWhen rationing a coronavirus vaccine, pharma must keep these 3 ethical considerations in mind
By Mike ReaJuly 23, 2020
vaccine injections
CommentaryHow to speed up medical breakthroughs in the post-COVID world
By Paul HudsonJuly 15, 2020
Photo of Covid-19 on stock exchange graph.
FinanceWill we have a COVID-19 vaccine this year? Here’s what the prediction markets say
By Jeremy KahnJuly 15, 2020
ASCO 2020 cancer drugs
NewslettersOne nonprofit’s ambitious new innovation for rare blood cancer patients
By Sy MukherjeeJuly 14, 2020
Kathy Giusti of MMRF_CureCloud
HealthA nonprofit just announced a 23andMe-like genomic sequencing model for a rare cancer—but it’s free
By Sy MukherjeeJuly 14, 2020
Gilead remdesivir coronavirus FDA
HealthGilead says remdesivir slashes coronavirus deaths. But it’s complicated
By Sy MukherjeeJuly 10, 2020
You can now sign up to participate in COVID-19 vaccine clinical trials
HealthYou can now sign up to participate in COVID-19 vaccine clinical trials
By Jonathan VanianJuly 8, 2020
In the COVID-19 vaccine race, nobody wins unless everyone wins
CommentaryIn the COVID-19 vaccine race, nobody wins unless everyone wins
By Seth BerkleyJuly 8, 2020
A dose of good news: Pfizer shares surge on coronavirus vaccine trial
FinanceA dose of good news: Pfizer shares surge on coronavirus vaccine trial
By Rey MashayekhiJuly 1, 2020
Gilead remdesivir coronavirus FDA
HealthCOVID treatment remdesivir will cost $520 per vial. But it may not be how much you pay
By Sy MukherjeeJune 29, 2020
Gilead coronavirus treatment drug Remdesivir
HealthGilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By Robert Langreth and BloombergJune 29, 2020
Gilead inhaled remdesivir trial
HealthGilead’s next COVID-19 treatment advancement could keep patients out of hospitals
By Sy MukherjeeJune 22, 2020
Court rules Trump can’t require drugmakers to disclose prices in TV ads
HealthCourt rules Trump can’t require drugmakers to disclose prices in TV ads
By The Associated PressJune 18, 2020
ADHD video game Akili FDA
HealthHow the first-ever digital ADHD treatment—a video game—got the FDA’s blessing
By Sy MukherjeeJune 17, 2020
Second wave coronavirus
NewslettersA second coronavirus wave isn’t imminent—the first one never ended
By Sy MukherjeeJune 11, 2020
1...
  • 33
  • 34
  • 35
  • 36
  • 37
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.